Cairo – Mubasher: Minapharm Pharmaceuticals reported standalone net profits of EGP 225.63 million in the first nine months of 2021, up by 134.8% year-on-year (YoY) from EGP 96.09 million.
The net sales rose to EGP 1.59 billion in the January-September period, compared to EGP 1.18 billion in the year-ago period, according to a bourse disclosure on Thursday.
In the first half (H1) of 2021, the company's consolidated net profits attributable to the company's owners amounted to EGP 255.63 million, compared to EGP 130.11 million in H1-20.
